Articles On Telix Pharmaceuticals (ASX:TLX)

MELBOURNE, Australia, Nov. 11, 2022 /PRNewswire/ – Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company), a commercial-stage biopharmaceutical company focused on the development and commercialisation of diagnostic and therapeutic...

ShareCafeMaterials leads market higher: ASX up 0.6% at close by Peter Milios   Materials is the strongest sector by far in today’s trading. This was due to the initial possibility that China would begin to ease COVID restrictions. As such,...

Highlights:  Australia’s highly comprehensive healthcare system consists of two broad categories, the public and the private healthcare system.  The public healthcare system is called Medicare, and it offers free healthcare services to...

ShareCafeStrict Chinese measures dampen market sentiment: ASX up 0.29% at lunch by Lauren Hayes   US markets finished higher on Friday after a volatile session following the release of the October jobs report, which showed better-than-expec...

Summary of Study Outcomes ZIRCON Phase III study of Telix’s investigational imaging agent TLX250-CDx in clear cell renal cell carcinoma (ccRCC) has met all of its primary and secondary endpoints The study delivered co-primary endpoints...

AusBiotech and Johnson & Johnson Innovation Industry Excellence Awards Industry Leadership Award: Professors Steve Wilton AO and Sue Fletcher AO Company of the Year: Telix Pharmaceuticals Emerging Company of the Year: Fusetec AusBi...

MELBOURNE, Australia, Oct. 27, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) is today pleased to announce that it has been awarded Australian Company of the Year in the 2022 AusBiotech and Johnson &...

MELBOURNE, Australia, Oct. 27, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces a collaboration with UniQuest Pty Ltd (UniQuest), the commercialisation company of The University of Queensla...

Australian shares were set to surge after hints of a slowdown in US interest rate rises fuelled a strong end to Wall Street’s best week since June. Wall Street’s main indices jumped more than 2.3 per cent on Friday, priming the S&P/A...

The ASX closed lower on Friday, extending its loss to over 1% for the week Coal and energy stocks gained, while insurance stocks fell Novonix in hot water with the ASX   Local shares fell close to 1% on Friday, ending what has been a vola...

The S&P/ASX 200 Index (ASX: XJO) ended the week in the red once more. The index fell 0.8% to 6,676.8 points on Friday. That leaves it 1.21% lower than it finished last week’s trade. It followed a rough Thursday for New York-listed st...

Highlights The ASX 200 benchmark index closed down today (21 October), losing 53.90 points or 0.80% to end at 6,676.80 points. Over the last five days, the index has lost 1.21% and 9.96% over the last 52 weeks. Utilities and materials...

The share market wrapped up a losing week with a second-straight decline as borrowing costs on both sides of the Pacific tested multi-year highs. The S&P/ASX 200 dropped 54 points or 0.8 per cent this afternoon to 6677. For the we...

ShareCafeGrim start to last trading day for the week: ASX down 0.8% by Peter Milios   Energy and Information Technology are the only sectors up at noon, as the ASX looks to close out a pretty moderate week. The energy sector got a boost fro...

A losing week on the ASX headed towards a downbeat conclusion as declines in banks and industrial companies outweighed slender gains in resource stocks. The S&P/ASX 200 fell 39 points or 0.6 per cent towards a second straight loss af...

27 new biotech companies listed on the ASX the last two years Australian companies need access to US capital to grow The AusBiotech investment conference kicks off next week in WA   The Covid-19 pandemic put Australia’s biotechnology sect...

Australian shares tracked Wall Street lower after the cost of borrowing rose and the jobs market showed early signs of slowing. The S&P/ASX 200 declined 69 points or 1.02 per cent to 6731. The retreat continued a burst of moves of...

Australian shares fell for the first time in three sessions as record results from energy giants Woodside and Santos were overshadowed by weak jobs data and renewed worries about rising rates. The S&P/ASX 200 dropped 78 points or 1.1...

It’s quarterlies season again as the ASX market announcements page becomes increasingly flooded with earnings lodgements.  The highlight today came from BNPL stock Zip, which reported strong growth. Is this the start of the BNPL turnaround...

In this week's Weekly Insights:-Investing In Non-Profitable Companies-Corporate Updates: Early Signals-Peak Resources?-FNArena TalksBy Rudi Filapek-Vandyck, Editor FNArenaInvesting In Non-Profitable CompaniesThe 2022 patience-testing, volat...

MELBOURNE, Australia, Oct. 20, 2022 /PRNewswire/ – Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today issues its Appendix 4C quarterly cash flow statement and accompanying Activities Report for the quarter ended 30 Septem...

A strong lead-in from Wall Street gave solid impetus to the Australian market on Tuesday, and the result was a lift of 114.8 points, or 1.7 per cent, in the benchmark S&P/ASX 200 (INDEXASX: XJO) Index, to 6779.2; while the broader S&amp...

ShareCafeEnergy only sector lagging: ASX closes 1.72% higher by Peter Milios   The ASX has continued rising since lunchtime. At the closing bell, the S&P/ASX 200 was 1.72 per cent or 114.80 points higher at 6779.20. The sector of the da...

ASX regains yesterday’s losses as volatility in the market continues All ASX sectors rose except Energy RBA deputy governor Michelle Bullock says RBA will keep lifting rates   The seesaw game continues as the ASX 200 gained 1.80% on Tuesd...

The S&P/ASX 200 Index (ASX: XJO) jumped higher on Tuesday, driven by tech shares. The index ended the day 1.72% higher at 6,779.2 points. Its strong performance followed Wall Street’s day in the green. The Dow Jones Industrial Averag...

The share market logged its highest close in a week and a half after a UK government backdown on a controversial tax plan helped trigger a massive relief rally on Wall Street. The S&P/ASX 200 jumped 115 points or 1.72 per cent to 677...

The S&P/ASX 200 Index (ASX: XJO) is back on form on Tuesday. In afternoon trade, the benchmark index is up 1.3% to 6,749.4 points. Four ASX shares that are climbing more than most today are listed below. Here’s why they are rising:...

The share market reversed yesterday’s loss after Wall Street welcomed a UK government decision to scrap unfunded tax cuts that sent tremors through financial markets.     The S&P/ASX 200 rallied 93 points or 1.39 per cent by mid-sess...

Telix (ASX:TLX) has announced that Health Canada has approved Illuccix gozetotide injection] for use in staging and re-staging intermediate and high-risk prostate cancer and localising tumour tissue in recurrent prostate cancer....

The S&P/ASX 200 Index (ASX: XJO) started the week out on the wrong foot. It fell 1.4% on Monday to close at 6,664.4 points. It followed a similarly disappointing Friday on Wall Street wherein the Dow Jones Industrial Average Index (DJX...

New agreement adds two Telix investigational PET imaging radiotracers to GE Healthcare’s immuno-diagnostic portfolio, to enable patient selection and monitoring in immunotherapy trials Telix tracers evaluate levels of carbonic anhydrase...

Telix Pharmaceuticals (TLX) has expanded its partnership with GE Healthcare via a deal to supply its investigational positron emission tomography (PET) imaging radiotracersThe company penned the collaborative development and reseller agreem...

Patrys crosses blood brain barrier in health animals Cynata receives Notice of Acceptance from IP Australia Telix announces collaboration with GE Healthcare Patrys (ASX:PAB) surged 15% this morning after announcing that its full-sized deo...

MELBOURNE, Australia, Oct. 17, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the Chinese National Medical Products Administration (NMPA) Center for Drug Evaluation (CDE) has approve...

ASX healthcare shares have been a mixed bag in 2022. The industry was flourishing during the later part of the last calendar year but took a turn as early as November. The downside continued along with the broader sell-off in equities....

Highlights The ASX 200 benchmark index closed up today, gaining 116.20 points or 1.75% to end at 6,758.80 points. Over the last five days, the index is virtually unchanged, but is down 9.21% for the last year to date. Energy was the b...

The ASX finished almost 2% higher on Friday, flat for the week UK-exposed stocks rose on potential policy U-turn by PM Liz Truss China’s inflation at 2-year high   The ASX tracked Wall Street higher today as the local index finished the d...

Telix Pharmaceuticals (TLX) gets approval from Health Canada for its imaging agent Illuccix for prostate cancer imagingThe company says Illuccix is the first PSMA PET imaging agent to be granted regulatory approval in Canada and is the thir...

Telix granted approval in Canda EBR Systems halt trading, pending a manufacturing change announcement   Telix Pharma (ASX: TLX) announced that Health Canada has approved lead product Illuccix for use in staging and re-staging prostate can...

The S&P/ASX 200 Index (ASX: XJO) closed in the red after spending most of today in the green. The index ended Thursday’s trade 0.07% lower at 6,642.6 points. Only one of the market’s sectors posted a notable gain today. The S&P/ASX...

During latest period of volatility many health stocks have seen their share prices remain quite stable Several ASX health stocks have rallied this week on positive news including Polynovo on $5 million sales month Telix Pharmaceuticals ral...

Highlights: The S&P/ASX 200 closed significantly up on Wednesday (05 October 2022), gaining 1.74% to 6,815.70 points. Ten out of eleven major sectors ended in green today. Information Technology ended 3.85% higher while the Consum...

The S&P/ASX 200 Index (ASX: XJO) recovered further from its September rout today. The index closed 1.74% higher at 6,815.70 points on Wednesday. It followed a strong session on Wall Street overnight that saw the Dow Jones Industrial Av...

The ASX gains another 1.7% on Wednesday All 11 sectors rose excepts Consumer Discretionary RBNZ raised cash rate by another 50bp   After the 3% surge yesterday, Aussie shares lifted another 1.7% on Wednesday as risk appetite makes its way...

The Imugene Limited (ASX: IMU) share price had a rough month despite multiple clinical trial updates. Imugene shares have fallen 30.77% from 26 cents at market close on 31 August to 18 cents at market close on 30 September....

Telix Pharmaceuticals (ASX: TLX) has announced it has withdrawn its application to market the company’s lead prostate cancer imaging product, Illuccix, in Europe. The Danish Medicines Agency asked for additional chemistry, manufacturing and...

MELBOURNE, Australia, Sept. 30, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces the first commercial dose in New Zealand of its prostate cancer imaging agent, Illuccix® (Kit for Preparatio...

Telix Pharmaceuticals (ASX:TLX) and GenesisCare, the largest provider of integrated cancer care in Australia, have announced that a first patient has been enrolled in the Phase 2 ProstACT TARGET study of prostate cancer antibody the...

ShareCafeASX erases yesterday’s gains: Aus shares close 0.5% lower by Lauren Hayes   It was choppy trading on the ASX today with the S&P/ASX 200 commencing the session in positive territory, before slipping into the red for afternoon tr...

Highlights: The ASX 200 benchmark index closed 0.53% lower to end at 6,462.00 points. Over the last five days, the index has lost 3.56% and has shed 11.18% over the last 52 weeks. IT was the worst performing sector, losing 1.61%....